SCHEMBL12313220

SCHEMBL12313220

COc1cc2cc(-n3cccc3)ccc2nc1-c1cc(C)cc(C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 8/20 0.41
▸ MAOB P27338 8/20 0.41
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ PDGFRB P09619 2/20 0.35
▸ PDGFRA P16234 2/20 0.35
▸ RORC P51449 1/20 0.34
▸ P2RX7 Q99572 2/20 0.34
▸ HTT P42858 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ ADORA1 P30542 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12313230 0.90 MAOA (0.39) MAOAMAOBMEN1ALDH1A1LMNA
SCHEMBL12313222 0.85 PDE10A (0.44) MAOAMAOBMEN1ALDH1A1KMT2A
SCHEMBL12313251 0.82 CYP19A1 (0.35) ALDH1A1LMNAHPGDSMN1; SMN2PDGFRB
SCHEMBL13870817 0.81 PDGFRB (0.44) MEN1ALDH1A1HPGDTSHRKMT2A
SCHEMBL12313223 0.80 MAOA (0.52) MAOAMAOBHPGDSMN1; SMN2POLB
SCHEMBL12313229 0.80 CYP19A1 (0.34) LMNAPKMPDGFRBPDGFRAHTT
SCHEMBL12313241 0.80 EHMT2 (0.32) PDGFRBPDGFRAHTTPOLBL3MBTL1
SCHEMBL13399629 0.77 PDGFRB (0.47) TSHRPDGFRBPDGFRAHTT
SCHEMBL12313228 0.76 PDE10A (0.43) MAOAMAOBMEN1ALDH1A1LMNA
SCHEMBL13870825 0.75 MEN1 (0.41) MEN1ALDH1A1LMNAHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263237-B2 Red phosphorescent composition and organic electroluminescent device using the same LG DISPLAY CO., LTD (KR) 2012-09-11 — — US disclosed
US-8263237-B2 Red phosphorescent composition and organic electroluminescent device using the same LG DISPLAY CO., LTD (KR) 2012-09-11 — — US disclosed
US-20100102714-A1 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2010-04-29 — — US disclosed
US-20100102714-A1 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2010-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100102714-A1 Red phosphorescent compound and organic electroluminescent device using the same YTHDC1, IK, PYCR1 MAOA 3569/4885MAOB 3019/4885MEN1 761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback